Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS

May 28, 2015 11:44 am | by ALS Therapy Development Institute | News | Comments

The ALS Therapy Development Institute announced it is directing, via its wholly owned subsidiary, Anelixis Therapeutics, $1.5 million toward the development of a potential treatment for ALS that targets the innate immune system. The funding comes from the $4 million the ALS Therapy Development Institute received from the 2014 social media phenomenon known as the “ALS Ice Bucket Challenge.”  Read more...

TOPICS:

CVS Purchase of Omnicare Fits the Long Term Care Trend: Kalorama

May 28, 2015 11:38 am | News | Comments

According to Kalorama Information, CVS Health Corporation's agreement of May 21 to acquire Omnicare for approximately $12.7 billion fits a prevailing trend in the healthcare industry – to seek to benefit from an aging population. Read more...

TOPICS:

Scientists Win $2.2 Million to Expand Study of Innovative Obesity Therapy

May 28, 2015 11:33 am | by The Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded nearly $2.2 million by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) to advance an innovative approach to the treatment of obesity, a serious health problem that affects more than one-third of all Americans. Read more...

TOPICS:
Advertisement

Sleeping Cancer Can ‘Wake Up’ Years Later

May 28, 2015 10:27 am | by Seth Augenstein, Digital Reporter | News | Comments

Years, even decades, after remission some cancers return without warning. The “sleeping” cancer cells reactivate, “waking up” decades later, according to a British team of scientists, who say they may have found the molecular key to the change. Read more...

TOPICS:

New Online Tool to Predict Genetic Resistance to TB Drugs

May 28, 2015 9:46 am | by London School of Hygiene & Tropical Medicine | News | Comments

Finding out what drugs can be used to treat a patient with tuberculosis (TB) can be sped up by days or weeks, thanks to a new free online tool. Read more...

TOPICS:

Scientists Identify Key to Preventing Secondary Cancers

May 28, 2015 9:36 am | by University of Sheffield | News | Comments

Scientists have identified a possible key to preventing secondary cancers in breast cancer patients, after discovering an enzyme which enhances the spread of the disease. Read more...

TOPICS:

EMA Validates Gilead's Marketing Application for HIV Treatment

May 28, 2015 9:26 am | News | Comments

Review of the MAA will be conducted by the EMA under the centralized procedure, which, when finalized, may lead to the grant of marketing authorization by the European Commission, which is valid in all 28 member states of the European Union. Read more...

TOPICS:

Salix Announces FDA Approval of IBS-D Treatment

May 28, 2015 9:20 am | News | Comments

The FDA approval was based on data from three clinical studies of more than 3,000 patients. Read more...

TOPICS:
Advertisement

NIH: Major Study Finds Earlier HIV Treatment Improves Health

May 28, 2015 9:13 am | by Lauran Neergard, AP Medical Writer | News | Comments

The findings are preliminary, but the NIH found them so compelling that it stopped the study a year early, so that all the participants could receive medication as researchers continue to track their health. Read more...

TOPICS:

Diagnosing Cancer with Help From Bacteria

May 28, 2015 9:07 am | by MIT | News | Comments

The earlier doctors can find these tumors, the more likely that they can successfully treat them. Read more...

TOPICS:

Par Specialty Pharmaceuticals Launches Cortisporin-TC Otic Suspension

May 27, 2015 2:16 pm | News | Comments

Par Specialty Pharmaceuticals, a division of Par Pharmaceutical, Inc., today announced the launch of Cortisporin®-TC Otic Suspension (colistin sulfate - neomycin sulfate - thonzonium bromide - hydrocortisone acetate otic suspension). Read more..

TOPICS:

U.S. Food and Drug Administration Approves Humalog Insulin Pen

May 27, 2015 2:13 pm | News | Comments

The U.S. Food and Drug Administration (FDA) has approved Humalog 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Read more...

Scientists are Designing Decoy Drugs to Fool Cancer

May 27, 2015 2:08 pm | by Columbia University Medical Center | News | Comments

A study published in Cancer Discovery describes how Jan Kitajewski, PhD, and colleagues have created new decoy drugs that can intercept the deceptive growth signals that cancer cells send out. Read more...

TOPICS:

FDA Approves Boehringer Ingelheim's COPD Inhalation Spray

May 27, 2015 1:53 pm | News | Comments

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray. Read more...

TOPICS:

Novartis, Rani Therapeutics Collaborate on Drug Delivery

May 27, 2015 1:46 pm | News | Comments

Rani Therapeutics announced today that it has entered into a collaboration with Novartis to evaluate Rani's novel oral biotherapeutics drug delivery platform. The companies have agreed to begin feasibility studies to evaluate how selected Novartis' proprietary biologics can be delivered into the bloodstream using Rani's unique route of administration. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading